Standard
Risk of ischemic heart and ischemic cerebrovascular disease is not increased in S, Z, and 11478A alpha1-antitrypsin carriers of the Copenhagen City Heart Study. / Dahl, Morten; Tybjaerg-Hansen, Anne; Nordestgaard, Børge G.
I:
Arteriosclerosis, Thrombosis, and Vascular Biology, Bind 23, Nr. 11, 01.11.2003, s. e55; author reply e55.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Dahl, M
, Tybjaerg-Hansen, A & Nordestgaard, BG 2003, '
Risk of ischemic heart and ischemic cerebrovascular disease is not increased in S, Z, and 11478A alpha1-antitrypsin carriers of the Copenhagen City Heart Study',
Arteriosclerosis, Thrombosis, and Vascular Biology, bind 23, nr. 11, s. e55; author reply e55.
https://doi.org/10.1161/01.ATV.0000097980.11819.93APA
Dahl, M.
, Tybjaerg-Hansen, A., & Nordestgaard, B. G. (2003).
Risk of ischemic heart and ischemic cerebrovascular disease is not increased in S, Z, and 11478A alpha1-antitrypsin carriers of the Copenhagen City Heart Study.
Arteriosclerosis, Thrombosis, and Vascular Biology,
23(11), e55; author reply e55.
https://doi.org/10.1161/01.ATV.0000097980.11819.93Vancouver
Dahl M
, Tybjaerg-Hansen A, Nordestgaard BG.
Risk of ischemic heart and ischemic cerebrovascular disease is not increased in S, Z, and 11478A alpha1-antitrypsin carriers of the Copenhagen City Heart Study.
Arteriosclerosis, Thrombosis, and Vascular Biology. 2003 nov. 1;23(11):e55; author reply e55.
https://doi.org/10.1161/01.ATV.0000097980.11819.93Author
Dahl, Morten ; Tybjaerg-Hansen, Anne ; Nordestgaard, Børge G. / Risk of ischemic heart and ischemic cerebrovascular disease is not increased in S, Z, and 11478A alpha1-antitrypsin carriers of the Copenhagen City Heart Study. I: Arteriosclerosis, Thrombosis, and Vascular Biology. 2003 ; Bind 23, Nr. 11. s. e55; author reply e55.
Bibtex
@article{ade1734d7d94449584e74465e426122f,
title = "Risk of ischemic heart and ischemic cerebrovascular disease is not increased in S, Z, and 11478A alpha1-antitrypsin carriers of the Copenhagen City Heart Study",
keywords = "Cerebrovascular Disorders, Disease Progression, Female, Heterozygote, Humans, Male, Myocardial Ischemia, Risk Assessment, alpha 1-Antitrypsin, alpha 1-Antitrypsin Deficiency",
author = "Morten Dahl and Anne Tybjaerg-Hansen and Nordestgaard, {B{\o}rge G}",
year = "2003",
month = nov,
day = "1",
doi = "10.1161/01.ATV.0000097980.11819.93",
language = "English",
volume = "23",
pages = "e55; author reply e55",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams & Wilkins",
number = "11",
}
RIS
TY - JOUR
T1 - Risk of ischemic heart and ischemic cerebrovascular disease is not increased in S, Z, and 11478A alpha1-antitrypsin carriers of the Copenhagen City Heart Study
AU - Dahl, Morten
AU - Tybjaerg-Hansen, Anne
AU - Nordestgaard, Børge G
PY - 2003/11/1
Y1 - 2003/11/1
KW - Cerebrovascular Disorders
KW - Disease Progression
KW - Female
KW - Heterozygote
KW - Humans
KW - Male
KW - Myocardial Ischemia
KW - Risk Assessment
KW - alpha 1-Antitrypsin
KW - alpha 1-Antitrypsin Deficiency
U2 - 10.1161/01.ATV.0000097980.11819.93
DO - 10.1161/01.ATV.0000097980.11819.93
M3 - Journal article
C2 - 14617620
VL - 23
SP - e55; author reply e55
JO - Arteriosclerosis, Thrombosis, and Vascular Biology
JF - Arteriosclerosis, Thrombosis, and Vascular Biology
SN - 1079-5642
IS - 11
ER -
